DUBLIN, Jan. 5, 2023 /PRNewswire/ — The “European Online Pharmacy Market: Analysis By Type (OTC and Rx), By Region Size And Trends With Impact Of COVID-19 And Forecast up to 2027” report has been added to ResearchAndMarkets.com’s offering.
The European online pharamacy market was valued at US$17.26 billion in 2021 and is expected to reach US$44.18 billion by 2027.
The online pharmacy market is a growing market with potentially new market entries who are striving to participate in the e-script market potential. This could potentially lead to pressure in the OTC business with more competitors in the Rx business along with an end to the post-covid boom in online pharmacy sales due to the diminishing impact from the pandemic and the return of the normal flu/cold season.
Several well-known brick and mortar pharmacy stores in Eastern Europe are shifting their focus to online sales channels in an effort to increase their customers. The market growth is also being driven by the growing consumer knowledge of the numerous additional advantages of online pharmacy services, including express delivery alternatives, open payment methods, cashback, discounted deals, etc. The European online pharamcy market is determined to grow at a CAGR of 16.95% over the forecasted period of 2022-2027.
Market Segmentation Analysis:
By Type: The report provides the bifurcation of online pharmacy market based on the type: Online OTC and Online Rx. Online OTC lead the market with the maximum share in 2021 owing to the increasing internet penetration and increasing knowledge of the benefits of online services, particularly for over-the-counter (OTC) medications.
By Region: In the report, the European online OTC pharamcy market is divided into the following regions: Germany, the UK, Italy, France, Spain, Netherlands, Belgium, Austria, and Rest of the Europe. Germany held the major share in the market owing to the increasing demand for online medications and doorstep delivery. The German retail pharma market stands out as the most significant market for online pharmacies in Europe given its size and regulation. While several large European markets are much less relevant as they have not opened prescription drugs (Rx) to mail-order.
The German online OTC pharmacy can be further divided into two segments based on type namely, BP (Beauty Products), HP (Healthcare Products), Nutrition, and Medicine-related OTC products. The BP, HP, Nutrition segment held the major share in the market.
Moreover, the report also provides the analysis of German Online Rx market. The online Rx pharmacy market is growing in Germany in the past few years driven by the convenience and cheaper costs of purchasing prescription drugs online, especially under the lockdown situation.
Growth Drivers: The European online pharamcy market has been growing over the past few years, due to factors such as the aging population, an increasing number of internet users, increasing healthcare e-commerce, convenience & lower pricing, increasing value-added services, etc. Value-added products/services are being offered by online pharmacies to widen their customer base, like e-Diagnostic services, appointments for a doctor consultation, e-Consultation, etc. In addition to online doctor services for consultations over the web, online pharmacies also strive to provide useful information about medications, diseases, and a healthy lifestyle. These services have widened the customer base of online pharmacies in the past few years, thus resulting in market growth.
Challenges: However, some challenges are impeding the growth of the market such as the regulatory environment, cyber threats & data security, increasing practice of illegal online pharmacies, concerns with inappropriate self-diagnosis, etc.
Trends: The market is projected to grow at a fast pace during the forecast period, due to various market trends like integration of AI in the pharmacy sector, rising implementation of e-prescriptions, escalating adoption of new technology, etc. Artificial intelligence improves the quality of services. It provides operational efficiency, accurate diagnosis, effective disease prevention, and daily health prevention to increase trust and customer loyalty.
The European online pharmacy market is fragmented. The key players in the European online pharmacy market are:
Zur Rose Group
Shop Apotheke Europe
Meds Apotek AB
UK Meds Direct Ltd.
Some of the strategies among key players in the market for online pharmacies are mergers, acquisitions, and collaborations. For instance, in 2022, the Zur Rose Group announced that the group had completed the operational integration of the Medpex brand at the Heerlen facility. On the other hand, Shop Apotheke Europe announced the successful opening of the company’s new distribution center in Milan, Italy. In 2021, Shop Apotheke was the major player in the German online pharmacy market followed by DocMorris.
Key Topics Covered:
1. Executive Summary
3. European Market Analysis
4. Regional Market Analysis
5. Impact of COVID-19
6. Market Dynamics
7. Competitive Landscape
8. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/58dv8u
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/european-online-pharmacy-market-report-2023-featuring-zur-rose-shop-apotheke-chemist4u-apotea-chemistdirect-parafarmacia-online-meds-apotek-lloydspharmacy-medexpress-uk-meds-direct–more-301714533.html
SOURCE Research and Markets
Amazon maintained its buy rating with one Wall Street analyst, and has had some other bullish news flow of late.
Shares of Chewy (NYSE: CHWY) were running 5% higher Wednesday morning as of 10:47 a.m. ET after the online pet products company was named this year's top stock by an analyst at Needham & Co. Analyst Anna Andreeva said she expects Chewy to pick up its pace of net sales per active customer (NSPAC) growth this year. As of the end of its fiscal third quarter on Oct. 30, Chewy had an active customer base of over 20.5 million people, up by 100,000 customers from a year prior, and its NSPAC jumped by 13.8% in the quarter to $477.
Shares of Carvana (NYSE: CVNA) were soaring today on an apparent short squeeze in shares of the struggling online seller of used cars, which could be approaching bankruptcy. The movement in Carvana comes as meme stocks like Bed Bath & Beyond, which is teetering on bankruptcy, and AMC Entertainment were rallying on a short squeeze, showing a coordinated effort to drive these stocks higher. Carvana was not previously part of the group of meme stocks that first got attention on Reddit's WallStreetBets page, but its low price and high short-selling ratio seem to have attracted the interest of the same crowd.
Shares of growth and technology companies are leading the market higher today, but alternative energy company Plug Power (NASDAQ: PLUG) was outpacing even the tech-heavy Nasdaq Composite index. While the Nasdaq was up by 1.1% as of 12:45 p.m. ET, Plug Power stock was higher by 6% at that time. Investors have been feeling better about growth stocks over the past few days as they anticipate inflation data to keep heading in the right direction, which could mean the Federal Reserve will slow interest rate hikes.
The Zacks Tobacco industry players are benefiting from solid pricing power as well as focus on innovation and expansion of low-risk products. These upsides bode well for Philip Morris (PM), British American Tobacco (BTI) and Turning Point Brands (TPB).
Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.
General Electric spinoff GE HealthCare Technologies (NASDAQ: GEHC) Shares were up 8.6% by 11:30 a.m. today. According to the release, organic fourth-quarter revenue growth will be a whopping 12%. Meanwhile, adjusted earnings before interest and taxation (EBIT) will come in above the $2.6 billion forecast on the investor day in December.
AbbVie (ABBV) closed the most recent trading day at $159.64, moving -1.25% from the previous trading session.
The past year has been terrible for Advanced Micro Devices (NASDAQ: AMD) investors as shares of the chipmaker have crashed 50% thanks to multiple headwinds that include the broader stock market sell-off owing to a hawkish Federal Reserve, slowing semiconductor demand, and concerns that the economy may be headed for a recession in 2023. AMD stock carries a price target of $87.50 for the next 12 months as per a consensus estimate of 38 analysts. Or will the semiconductor market's weakness catch up with AMD and send the stock lower?
GMAB, OSW, ACDC, EVBG and MTG have been added to the Zacks Rank #1 (Strong Buy) List on January 11 , 2023.
Laffer Tengler Investments CEO and Chief Investment Officer Nancy Tengler joins Yahoo Finance Live to discuss the state of Tesla stock amid its recent struggles, why earnings season could bring disappointment for investors, and the odds of a recession.
In this article, we discuss the 11 biggest BNPL companies in the world. If you want to read about some more BNPL companies, go directly to 5 Biggest BNPL Companies In The World. Digital payment options have gained immense popularity in recent years. These payment options are more popular in Europe and US, but are […]
Here are two highly-ranked stocks that could end up being bargains from their current levels as we progress through 2023.
Yahoo Finance Live’s Brian Sozzi discusses a Citi analyst’s bullish pre-earnings calls on Tesla.
A mild stock market rally to kick off the new year will be put to the test Thursday when investors face a highly-awaited inflation reading which could well help determine the size of the Federal Reserve’s next interest-rate increase.
In this article, we will discuss the 12 best up-and–coming stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Best Up-and-Coming Stocks to Buy Now. 2022 has been the worst year for growth stocks, and stocks in general, since 2008. The runaway inflation we had […]
In the first of what's apparently intended to be an annual series, SoFi released its SoFi Investor Study. For the latter period, most (93%) of the respondents continued to invest in various financial investments despite the often high market volatility. Certificates of desposits (CDs) and real estate investment trusts (REITs) also served as popular alternatives.
Choosing solid dividend stocks can be tricky. Buying a stock with a really high dividend yield is tempting, but many stocks with high dividends got that way because their share prices have plummeted. Many stocks with high yields also have high dividend payout ratios, meaning a company devotes much of its earnings to those dividends.
Cybersecurity software falls into this bucket, which leads to the question of which cybersecurity stocks are the best to buy. Two popular cybersecurity investments are CrowdStrike (NASDAQ: CRWD) and Okta (NASDAQ: OKTA), and for a good reason: They are the go-to solutions in their respective offerings. Instead, multiple companies provide different methods to create effective protection.
GE HealthCare Technologies' shares rose Wednesday after the company issued preliminary results for the fourth quarter and forecasted continued organic revenue growth in the year ahead. The company, which [completed its spinoff](https://www.wsj.com/livecoverage/stock-market-news-today-01-04-2023/card/ge-healthcare-spinoff-starts-trading-WpvaxRCwO5Vfht5JyHEo) from General Electric last week, said it expects 2023 organic revenue to grow by 5% to 7% from 2022 levels. In 2022, organic revenue grew by